CD274 and neoplasm: The diagnostic potential of circulating PD-L1 was inferior to established tumor markers such as CEA (AUC: 0.816) and CA19-9 (AUC: 0.885) when used as a single marker for the differentiation between BTC patients and healthy controls (Figure 1C).